Dengue and yellow fever virus are significant human pathogens that cause hemorrhagic fever and fatalities. Currently, there are no approved antivirals for these viruses. The development of antivirals for RNA viruses has proven to be particularly difficult due to the rapid emergence of drug resistant viruses. This is primarily due to the error prone nature of the polymerase, which results in rapid evolution of the virus under selective pressure. Targeting a host factor for which the virus does not have any genetic control over should decrease or prevent development of resistant mutants either because the virus cannot function without the host factor or because more mutations are required to confer resistance. Towards this goal we have developed a robust method to identify host factors that are bound to the viral RNA during viral amplification in cell culture. We will use this method to identify host factors that are bound to the dengue virus and yellow fever virus RNA. We will identify which host factors will be good targets to develop antiviral targets. In addition, we will also determine the step in the viral life cycle the host factors participate in and the protein-protein and protein-viral RNA interactions for that host factor during viral infection. These studies will address the mechanism of the host factor in viral amplification and enable development of a high-throughput assay fro inhibitors of the host factor.
RNA viruses rapidly evolve resistant viruses to antiviral that target the viral proteins. An antiviral that targets a host protein would significantly reduce or prevent drug resistance. Therefore, we will identify host factors that interact with dengue and yellow fever viral RNAs and determine their role in the viral life cycle in order to identify an effective antiviral target.
|Budayeva, Hanna G; Rowland, Elizabeth A; Cristea, Ileana M (2016) Intricate Roles of Mammalian Sirtuins in Defense against Viral Pathogens. J Virol 90:5-8|
|GiguÃ¨re, Sophie S B; Guise, Amanda J; Jean Beltran, Pierre M et al. (2016) The Proteomic Profile of Deleted in Breast Cancer 1 (DBC1) Interactions Points to a Multifaceted Regulation of Gene Expression. Mol Cell Proteomics 15:791-809|
|Viktorovskaya, Olga V; Greco, Todd M; Cristea, Ileana M et al. (2016) Identification of RNA Binding Proteins Associated with Dengue Virus RNA in Infected Cells Reveals Temporally Distinct Host Factor Requirements. PLoS Negl Trop Dis 10:e0004921|
|Ashford, Paul; Hernandez, Anna; Greco, Todd Michael et al. (2016) HVint: A Strategy for Identifying Novel Protein-Protein Interactions in Herpes Simplex Virus Type 1. Mol Cell Proteomics 15:2939-53|
|Song, Ren; Koyuncu, Orkide O; Greco, Todd M et al. (2016) Two Modes of the Axonal Interferon Response Limit Alphaherpesvirus Neuroinvasion. MBio 7:e02145-15|
|Lum, Krystal K; Cristea, Ileana M (2016) Proteomic approaches to uncovering virus-host protein interactions during the progression of viral infection. Expert Rev Proteomics 13:325-40|
|Guise, Amanda J; Cristea, Ileana M (2016) Approaches for Studying the Subcellular Localization, Interactions, and Regulation of Histone Deacetylase 5 (HDAC5). Methods Mol Biol 1436:47-84|
|Diner, Benjamin A; Lum, Krystal K; Javitt, Aaron et al. (2015) Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression. Mol Cell Proteomics 14:2341-56|
|Cristea, Ileana M; Graham, David (2015) Virology meets Proteomics. Proteomics 15:1941-2|
|Orzalli, Megan H; Broekema, Nicole M; Diner, Benjamin A et al. (2015) cGAS-mediated stabilization of IFI16 promotes innate signaling during herpes simplex virus infection. Proc Natl Acad Sci U S A 112:E1773-81|
Showing the most recent 10 out of 18 publications